Quantification of contrast-uptake as imaging biomarker for disease progression of renal cell carcinoma after tumor ablation.
Bruno R TegelSteffen HuberLynn Jeanette SavicMingDe LinBernhard GebauerJeffrey PollakJulius ChapiroPublished in: Acta radiologica (Stockholm, Sweden : 1987) (2020)
ETV, as surrogate of lesion vascularity, is a sensitive imaging biomarker for occurrence of extra-renal metastatic disease and PFS in patients with RCC.